Bioharvest Sciences (BHST) Cash & Equivalents (2023 - 2026)
Bioharvest Sciences (BHST) reported Cash & Equivalents of $15.21 million for the quarter ended Jun 30, 2026, up 308.1% from $3.73 million a year earlier but down 20.6% from the prior quarter.
Powered by 
Analysis
Bioharvest Sciences (BHST) Cash & Equivalents (2023 - 2026) Analysis & Trends
As of Dec 31, 2025, Bioharvest Sciences posted Cash & Equivalents of $23.03 million, up 863.4% from the prior year.
- By year, Cash & Equivalents came in at $2.39 million in the year ended Dec 31, 2024 (-55.4%) and $5.36 million in the year ended Dec 31, 2023.
- Five-year quarterly Cash & Equivalents spans a low of $1.56 million in the quarter ended Sep 30, 2023 and a high of $23.03 million in the quarter ended Dec 31, 2025.
- Year over year, Cash & Equivalents has now increased in each of the last four quarters, with growth averaging 233.0% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was the quarter ended Dec 31, 2025 (growth of 863.4%); the low point was the quarter ended Dec 31, 2024 (a decline of 55.4%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $19.17 million (quarter ended Mar 31, 2026), $23.03 million (quarter ended Dec 31, 2025) and $10.97 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Bioharvest Sciences | 27.06 Mn | -43.32 Mn | 5.08 Mn | 15.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.21 Mn |
| Mar 31, 2026 | 19.17 Mn |
| Dec 31, 2025 | 23.03 Mn |
| Sep 30, 2025 | 10.97 Mn |
| Jun 30, 2025 | 3.73 Mn |
| Mar 31, 2025 | 3.40 Mn |
| Dec 31, 2024 | 2.39 Mn |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.17 Mn |
| Mar 31, 2024 | 5.36 Mn |
| Dec 31, 2023 | 5.36 Mn |
| Sep 30, 2023 | 1.56 Mn |
| Jun 30, 2023 | 1.81 Mn |
API Access
Bioharvest Sciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BHST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BHST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BHST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();